SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-18-003188
Filing Date
2018-04-30
Accepted
2018-04-30 16:22:02
Documents
5
Period of Report
2018-04-30
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a_043018.htm DEF 14A 324727
2 GRAPHIC sig1.jpg GRAPHIC 6483
3 GRAPHIC proxy1.jpg GRAPHIC 114165
4 GRAPHIC proxy2.jpg GRAPHIC 48564
5 GRAPHIC proxy3.jpg GRAPHIC 209797
  Complete submission text file 0001171843-18-003188.txt   848246
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37347 | Film No.: 18790100
SIC: 2834 Pharmaceutical Preparations